31
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7700 | Lersivirine | Lersivirine(UK 453061),UK-453061 | HIV Protease , Reverse Transcriptase |
Lersivirine (UK-453061)(UK 453061) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV infection therapy. | |||
T7212 | Delavirdine mesylate | U 90152 (mesylate),BHAP-U 90152 (mesylate),Delavirdine (mesylate) | HIV Protease , Reverse Transcriptase |
Delavirdine mesylate (BHAP-U 90152 (mesylate)) is a non-nucleoside reverse transcriptase inhibitor (NNRTI). | |||
T2330 | Rilpivirine | TMC278,R278474,DB08864 | HIV Protease , Reverse Transcriptase |
Rilpivirine (R278474) is a diarylpyrimidine derivative and reverse transcriptase inhibitor with antiviral activity against HIV-1 that is used in the treatment of HIV infections. | |||
T78948 | NNRTIs-IN-1 | ||
NNRTIs-IN-1 is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI) with notable anti-resistance efficacy, effectively inhibiting both the wild-type HIV-1 and five mutant strains at EC50 values within the nano... | |||
T78737 | NNRTIs-IN-3 | HIV Protease | |
NNRTIs-IN-3 (compound 8) is an HIV-1 non-nucleoside reverse transcriptase inhibitor, displaying potent efficacy with an EC50 value of 0.01 µM [1]. | |||
T31860 | Fosdevirine | GSK-2248761A,IDX 899,GSK 2248761A,GSK 2248761,GSK-2248761,IDX-12899,GSK2248761,FDV,GSK2248761A | HIV Protease |
Fosdevirine (GSK2248761) is a selective and potent non-nucleoside reverse transcriptase (NNRTI) inhibitor with anti-HIV activity for the study of neurological related disorders such as late-onset epilepsy. | |||
T31860L | (Iso)-Fosdevirine | (Iso)-Fosdevirine(Iso-1018450-26-4),(Iso)-GSK2248761 | HIV Protease |
(Iso)-Fosdevirine ( (Iso)-GSK2248761) is a selective and potent non-nucleoside reverse transcriptase (NNRTI) inhibitor with anti-HIV activity for the study of neurological disorders such as late-onset epilepsy. | |||
T9223 | RO-0335 | Reverse Transcriptase | |
RO-0335 is a potent diphenylether nonnucleoside reverse transcriptase inhibitor. RO-0335 inhibits Wt HIV-1 (IC50 = 1.1 nM) and retained activity (IC50< 100 nM) against 92% of a large number of NNRTI-resistant clinical is... | |||
T29037 | UC-781 | NSC 675186,UC781,UC 781 | Antiviral , HIV Protease |
UC-781 (NSC-675186) is a potent and selective inhibitor of human immunodeficiency virus HIV-1 non-nucleoside reverse transcriptase (NNRTI) I with a C50 value of 5 nM.UC-781 exhibits both antiviral activity and drug resis... | |||
T27625 | IQP-0528 | SJ-3991,SJ3991,IQP0528 | Antiviral , HIV Protease , Reverse Transcriptase |
IQP-0528 is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI) that has potential for the treatment of HIV infection by blocking viral entry and shows antiviral activity as a microbicidal gel. . IQP-0528 sho... | |||
T71517 | Nevirapine quinone methide | ||
Nevirapine quinone methide is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS. | |||
T31085 | CP-94707 | UNII-YGC6408B5O | |
CP-94707 is a new inhibitor of nonnucleoside reverse transcriptase (NNRTI). | |||
T26442 | A 75925 | A-75925,A75925 | |
A 75925, a nonnucleoside reverse transcriptase inhibitors (NNRTI), works to inhibit HIV-1 replication. | |||
T70794 | Nevirapine dimer | ||
Nevirapine dimer is a non-nucleoside reverse transcriptase inhibitor (NNRTI). | |||
T72582 | HIV-1 inhibitor-48 | ||
HIV-1 inhibitor-48 is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) and exhibits anti-HIV-1 activity . | |||
T70156 | K-5a2 | ||
K-5a2 is a novel human immunodeficiency virus type 1 (HIV-1) non-nucleoside reverse transcriptase inhibitor (NNRTI). | |||
T69796 | Nevirapine hemihydrate | ||
Nevirapine hemihydrate is a non-nucleoside reverse transcriptase inhibitor (NNRTI) studied for potential treatment of HIV-1 infection and AIDS. | |||
T27442 | GSK 224876 | GSK-224876,GSK224876 | |
GSK 224876 is a novel next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI). It has activity against efavirenz-resistant strains in the treatment of treatment-naive HIV-1-infected subjects. | |||
T11247 | Etravirine D4 | R-165335 D4,TMC-125 D4 | Others |
Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV. Etravirine D4 is the deuterium labeled Etravirine. | |||
T7212L | Delavirdine | Rescriptor,DLV,U 90152,BHAP-U 90152 | |
Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Delavirdine is part of Highly Active Antiretroviral Therapy (HAART), which can be used to treat human immunodeficiency virus (HIV) type 1. | |||
T79837 | Bavtavirine | ||
Bavtavirine, a potent non-nucleoside reverse transcriptase inhibitor (NNRTI), forms an integral component of the highly active antiretroviral therapy (HAART) regimen for HIV disease research [1]. | |||
T63677 | HIV-1 inhibitor-13 | ||
HIV-1 inhibitor-13 is an orally active HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) with an IC50 value of 0.14 μM against HIV-1 RT. HIV-1 inhibitor-13 is active against HIV-1 resistant strains (EC50: 2.85... | |||
T62452 | HIV-1 inhibitor-40 | ||
HIV-1 inhibitor-40 (Compound 4ab) is an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) (EC50: 1.9 nM) with no significant acute toxicity in vivo. Orexin receptor antagonist is a highly sensitive inhibitor o... | |||
T72566 | HIV-1 inhibitor-50 | ||
HIV-1 inhibitor-50 is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that targets HIV-1 reverse transcriptase (IC50 = 50 nM). HIV-1 inhibitor-50 shows significant antiviral activity, with EC50s of 2.22-53.3nM a... | |||
T63363 | HIV-1 inhibitor-19 | ||
HIV-1 inhibitor-19 is a potent inhibitor of HIV-1 non-nucleoside reverse transcriptase (NNRTI) that acts on L100I, K103N and V106A/F227L mutant strains with EC50s of 7.3 nM, 9.2 nM and 21.0 nM, respectively. | |||
T74516 | CI-39 | ||
CI-39, a natural antiviral product, serves as a non-nucleoside reverse transcriptase inhibitor (NNRTI) targeting wild type HIV-1. It exhibits an effective concentration (EC50) of 3.40 µM against the virus, while its cyto... | |||
T78749 | HIV-1 inhibitor-57 | ||
HIV-1 Inhibitor-57 (Compound 12g) is an antiviral agent that potently inhibits both wild-type and five common NNRTI-resistant strains of HIV-1, exhibiting EC50 values between 0.024 and 0.0010 μM. It achieves this efficac... | |||
T62526 | HIV-1 inhibitor-8 | ||
HIV-1 inhibitor-8 is a potent, orally active, low toxicity HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI). HIV-1 inhibitor-8 is capable of acting on WT HIV-1 reverse transcriptase (IC50: 0.081 μM). HIV-1 in... | |||
T26581 | AIC-292 | ||
AIC-292 is a potent reverse transcriptase inhibitor with well tolerated in different cell lines. In addition, activity of AIC292 could be demonstrated against a broad panel of wild-type HIV-1 group. AIC292 also retained ... | |||
T78925 | HIV-1 inhibitor-58 | ||
HIV-1 Inhibitor-58 (Compound 10c) is a non-nucleoside reverse transcriptase inhibitor with broad-spectrum antiviral properties, effective against both wild-type strain IIIB and NNRTI-resistant strains like K103N and E138... | |||
T61311 | HIV-1 inhibitor-30 | ||
HIV-1 inhibitor-30 (compound 10i) is a potent inhibitor of HIV-1, specifically targeting the RT DNA polymerase enzyme. It exhibits strong antiretroviral activity, with an EC 50 value of 40 nM and an IC 50 value of 80 nM.... |